scispace - formally typeset
Open AccessJournal ArticleDOI

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

TLDR
A global multistage systematic review of sharing of equipment used for injecting drug use (IDU) identified evidence of IDU in more countries than in 2008, with the new countries largely consisting of low-income and middle-income countries in Africa.
About
This article is published in The Lancet Global Health.The article was published on 2017-12-01 and is currently open access. It has received 951 citations till now. The article focuses on the topics: Disease burden & Population.

read more

Citations
More filters
Journal ArticleDOI

EASL Recommendations on Treatment of Hepatitis C

TL;DR: The optimal management of patients with acute and chronic HCV infections in 2018 and onwards is described, as well as developments in diagnostic procedures and improvements in therapy and prevention.
Journal ArticleDOI

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.

TL;DR: The PRISMA-S (Preferred Reporting Items for Systematic reviews and Meta-Analyses literature search extension) checklist as discussed by the authors was developed using a 3-stage Delphi survey process, followed by a consensus conference and public review process.
Journal ArticleDOI

EASL recommendations on treatment of hepatitis C: Final update of the series ☆

TL;DR: These European Association for the Study of the Liver recommendations on treatment of hepatitis C describe the optimal management of patients with recently acquired and chronic HCV infections in 2020 and onwards.
Journal ArticleDOI

Lancet Seminar – Hepatitis C

TL;DR: Advances in HCV cell culture have enabled improved understanding of HCV virology, which has led to development of many new direct-acting antiviral drugs that target key components of virus replication, allowing for simplified and shortened treatments for HCV that can be given as oral regimens with increased tolerability and efficacy.
References
More filters
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Journal ArticleDOI

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

TL;DR: More IDUs have anti-HCV than HIV infection, and viral hepatitis poses a key challenge to public health, which will inform efforts to prevent and treat HCV and HBV in IDUs.
Related Papers (5)

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Sarah Blach, +221 more